ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 296

Prevalence of Elbow Arthritis in Patients with Rheumatoid Arthritis: A Prospective Ultrasound Study

Diana Vossen 1, Valentin Schaefer2, Florian Recker 3, Isabelle Geffken 4, Eva Matuschek 5 and Wolfgang Hartung 6, 1Departement for Internal Medicine and Rheumatology, Rheinisches Rheumazentrum Meerbusch, St. Elisabeth-Hospital, Meerbusch, Germany; German Society for Rheumatology (Working Group Young Rheumatology), Meerbusch, Germany, 2Medical Clinic III , Rheumatology und clinical Immunology, University Hospital Bonn, Bonn, Germany, 31. Medical Clinic III , Rheumatology und clinical Immunology, University Hospital Bonn and 2. Department for Obstetrics and Gynecology, University Hospital Bonn, Bonn, Germany, 4Departement for Internal Medicine and Rheumatology, Rheinisches Rheumazentrum Meerbusch, St.Elisabeth Hospital, Düsseldorf, Germany, 5Department for Internal Medicine, Dreifaltigkeits-Krankenhaus Wesseling, bonn, Germany, 6Rheumatology und clinical Immunology, Asklepios Klinik, 93077 Bad Abbach, Bad Abbach, Germany

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: rheumatoid arthritis, Rheumatoid arthritis (RA), synovium and arthritis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Imaging Of Rheumatic Diseases Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Musculoskeletal ultrasound is an important imaging method in the diagnosis of arthritis, especially rheumatoid arthritis (RA). The prevalence of elbow joint arthritis in RA has not yet been specifically investigated sonographically and correlated with the clinical examination and other parameters.

Methods: In 100 patients with RA and 50 patients without rheumatological disease both cubital joints were examined according to the 3 most relevant standard planes (anterior longitudinal humeroradial and humeroulnar as well as posterior longitudinal scans) of the German Society for Ultrasound in Medicine (DEGUM). A complete clinical examination was performed and baseline characteristics (age, sex, etc.), DAS28 and visual analogue scale (VAS) were recorded. Elbow arthritis was defined as joint effusion grade II and/or hyperperfusion of the synovial proliferation. The patients were recruited in the department of Rheumatology of the University Hospital Bonn as well as in the Rheinischen Rheumazentrum Meerbusch. The ultrasound examination was performed by two very experienced physicans (DEGUM level I and DEGUM level II, equals EFSUMB levels). The statistical evaluation was performed with IBM SPSS (Version 25). A p-value < 0.05 was considered significant. The interrater analysis was assesed by Cohen’s kappa, as well as by an independent blinded assessor (DEGUM III, equal EFSUMB III).

Results: Mean age was 59.8 years (±SD 15.9) in the RA cohort and 59.8 years (±SD 16.2) in the control group. The RA cohort displayed relevant joint effusion in 54.9%, in 6.9% hypervascularization was visible, whereas in the control group 16% displayed joint effusion and none showed hypervascularization. The mean DAS28 in the RA cohort was 5.3 (±SD 1.1; high activity 56.9% (DAS28 > 5.1), moderate activity 41.1% (DAS28 > 3.2), low activity (DAS28 > 2.6) 2%). The mean VAS in RA patients was 6.41 (±SD 2.3), and 2.42 (± 2.9) in the control group.

In the RA cohort there was a significant correlation between movement restriction (MR) and joint effusion (p-value = 0.001), between DAS28 and MR (p-value = 0.02) and between DAS28 and sonographic joint effusion (p-value = 0.022). The overall collective showed a significant correlation of DAS28 with MR and joint effusion [figure 1].

In overall analysis, a highly significant correlation of VAS with MR (p-value 0.001), the presence of joint effusion (p-value 0.001) and the diagnosis of RA (p-value 0.001) was observed.

Interrater analysis showed good agreement with Cohen´s kappa of 0,896 and a highly significant p-value of 0.001.

Conclusion: This is the first study to investigate the prevalence of elbow joint effusion and synovitis in RA patients. It shows, that the prevalence of elbow joint arthritis is high, with over 54% in the RA cohort. Movement restriction is a good indicator of elbow joint arthritis in RA, but not in all RA patients. In the overall analysis of both cohorts, there is a strong correlation between VAS with joint effusion and MR (p-value 0.001) [Figure 2].


Graphs elbow study

figure 1 and figure 2


Disclosure: D. Vossen, None; V. Schaefer, None; F. Recker, None; I. Geffken, None; E. Matuschek, None; W. Hartung, None.

To cite this abstract in AMA style:

Vossen D, Schaefer V, Recker F, Geffken I, Matuschek E, Hartung W. Prevalence of Elbow Arthritis in Patients with Rheumatoid Arthritis: A Prospective Ultrasound Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-elbow-arthritis-in-patients-with-rheumatoid-arthritis-a-prospective-ultrasound-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-elbow-arthritis-in-patients-with-rheumatoid-arthritis-a-prospective-ultrasound-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology